PDCD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.4892004537096E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.87529996770786E-09 |
Normal-vs-Stage2 |
2.25039999999233E-05 |
Normal-vs-Stage3 |
7.23110016309647E-10 |
Normal-vs-Stage4 |
6.29799999999348E-05 |
Stage1-vs-Stage2 |
7.849200E-01 |
Stage1-vs-Stage3 |
1.545830E-01 |
Stage1-vs-Stage4 |
6.286600E-01 |
Stage2-vs-Stage3 |
4.968600E-01 |
Stage2-vs-Stage4 |
6.011000E-01 |
Stage3-vs-Stage4 |
1.485970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.61660004774456E-09 |
Normal-vs-AfricanAmerican |
5.28349999973088E-07 |
Normal-vs-Asian |
1.640670E-03 |
Caucasian-vs-AfricanAmerican |
8.237400E-01 |
Caucasian-vs-Asian |
3.440200E-01 |
AfricanAmerican-vs-Asian |
3.300000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.58709999587003E-08 |
Normal-vs-Female |
6.71629973858501E-10 |
Male-vs-Female |
9.684800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.579390E-04 |
Normal-vs-Age(41-60Yrs) |
8.09830003056788E-09 |
Normal-vs-Age(61-80Yrs) |
3.4035000040511E-08 |
Normal-vs-Age(81-100Yrs) |
2.14629999999438E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.554800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.881400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.400800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.346600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.639200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.327200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.779690E-02 |
Normal-vs-Grade 2 |
2.14740000004099E-07 |
Normal-vs-Grade 3 |
4.43040049091792E-11 |
Normal-vs-Grade 4 |
5.2517000004304E-07 |
Grade 1-vs-Grade 2 |
8.641400E-01 |
Grade 1-vs-Grade 3 |
3.112000E-01 |
Grade 1-vs-Grade 4 |
4.349000E-01 |
Grade 2-vs-Grade 3 |
1.570060E-02 |
Grade 2-vs-Grade 4 |
1.607840E-01 |
Grade 3-vs-Grade 4 |
9.039600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.51610000001623E-06 |
Normal-vs-ccB subtype |
3.13770009974235E-10 |
ccA subtype-vs-ccB subtype |
1.278470E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.34250000017167E-07 |
Normal-vs-N1 |
1.604260E-04 |
N0-vs-N1 |
1.819560E-01 |
|
|